Energenesis Biomedical CO.,LTD. (TPE:6657)

TPE:6657 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	567.38	673.1	404.51	246.61	90.2	149.37
Short-Term Investments	110	165	260.47	452.59	394.47	576.47
Cash & Short-Term Investments	677.38	838.1	664.98	699.2	484.67	725.84
Cash Growth	-29.04%	26.03%	-4.89%	44.26%	-33.23%	33.45%
Accounts Receivable	1.1	1.39	0.85	0.93	1.53	1.31
Other Receivables	3.09	18.69	16.96	14.63	11.48	8.7
Receivables	4.19	20.08	17.81	15.56	13.01	10.01
Inventory	1.03	0.9	0.75	0.73	0.59	0.69
Prepaid Expenses	21.12	5.32	4.17	3.92	5.18	3.42
Other Current Assets	0.02	0.02	0.04	0.04	0.04	0.03
Total Current Assets	703.74	864.43	687.75	719.44	503.49	739.98
Property, Plant & Equipment	75.43	78.72	75.79	77.22	82.51	89.02
Other Intangible Assets	0.02	1.06	13.67	26.32	38.96	51.48
Other Long-Term Assets	4.88	4.77	3.43	5.59	5.9	5.32
Total Assets	784.06	948.98	780.64	828.57	630.86	885.81

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.1	0.39	0.31	0.34	0.37	0.3
Accrued Expenses	-	31.49	27.07	12.47	13.88	12.41
Current Portion of Leases	4.89	5.55	4.56	5.04	5.59	5.75
Other Current Liabilities	59.29	5.99	3.9	3.5	4.52	8.8
Total Current Liabilities	64.29	43.42	35.83	21.34	24.36	27.24
Long-Term Leases	6.85	9.29	5.47	3.24	3.95	6.19
Total Liabilities	71.14	52.71	41.31	24.59	28.31	33.44

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	888.08	888.08	764.94	760.25	668.45	663.71
Additional Paid-In Capital	58.68	534.09	64.62	393.9	199.77	307.62
Retained Earnings	-194.24	-489.48	-231.08	-350.67	-265.66	-120.24
Treasury Stock	-39.59	-36.35	-	-	-	-
Comprehensive Income & Other	-0	-0.07	140.85	0.5	-	1.29
Shareholders' Equity	712.93	896.27	739.33	803.98	602.56	852.38
Total Liabilities & Equity	784.06	948.98	780.64	828.57	630.86	885.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11.74	14.84	10.03	8.28	9.54	11.94
Net Cash (Debt)	665.64	823.26	654.95	690.92	475.13	713.91
Net Cash Growth	-29.42%	25.70%	-5.21%	45.41%	-33.45%	34.96%
Net Cash Per Share	7.53	9.31	8.58	9.59	7.13	11.89
Filing Date Shares Outstanding	87.66	87.98	76.49	76.03	66.85	66.37
Total Common Shares Outstanding	87.66	87.98	76.49	76.03	66.85	66.37
Working Capital	639.45	821.01	651.91	698.1	479.12	712.74
Book Value Per Share	8.13	10.19	9.67	10.58	9.01	12.84
Tangible Book Value	712.91	895.21	725.66	777.67	563.59	800.89
Tangible Book Value Per Share	8.13	10.18	9.49	10.23	8.43	12.07
Land	-	54.03	54.03	54.03	54.03	54.03
Buildings	-	7.06	7.06	7.06	7.06	7.06
Machinery	-	27.58	26.01	25.26	24.91	24.26
Leasehold Improvements	-	5.13	5	5	5	5

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error